WORLD Orphan Drug Congress USA
Boston
USA
Del
to
Access to innovation
Rare diseases
The congress brings together leading pharmaceutical and biotechnology companies, government and regulatory authorities, patient advocacy groups, investors, and solution providers. This conference provides a forum to discuss and promote the development of orphan drugs and improve access to therapies for rare diseases.
More information here.